Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Altimmune Inc (NASDAQ:ALT)

3.80
Delayed Data
As of Jun 21
 +0.06 / +1.60%
Today’s Change
2.59
Today|||52-Week Range
14.70
-1.06%
Year-to-Date
No recent news for Altimmune Inc.

Today’s Trading

Previous close3.74
Today’s open3.74
Day’s range3.60 - 3.97
Volume99,895
Average volume (3 months)164,742
Market cap$58.7M
Dividend yield--
Data as of 06/21/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-50.85%
P/E ratio1.3
Price/Sales40.80
Price/Book1.32

Competitors

 Today’s
change
Today’s
% change
AKTXAkari Therapeutics P...+0.28+5.89%
SNESSenesTech Inc-0.05-0.83%
LPTXLeap Therapeutics In...-0.04-0.67%
SRRASierra Oncology Inc+0.05+4.42%
Data as of 06/21/2017

Financials

Last reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$5.2M
Annual profit (last year)$193.9M
Net profit margin3,706.44%

Profile

Sector
Commercial Services
Industry
Miscellaneous Commercial Services
President, Chief Executive Officer &
Director
William Enright
CFO, Secretary &
EVP-Corporate Development
Elizabeth Adkins Czerepak
Corporate headquarters
Gaithersburg, Maryland

Forecasts